
Immunising infants and older people against RSV found to not be cost-effective - HIQA
28/4/2026
0:00
2:54
Dr. Máirín Ryan, HIQA Director of Health Technology Assessment, explains its assessment of immunisation programmes against RSV.
See omnystudio.com/listener for privacy information.
Otros episodios de "Morning Ireland"



No te pierdas ningún episodio de “Morning Ireland”. Síguelo en la aplicación gratuita de GetPodcast.








